Patent directory · USPTO A61K / A61P
Patents matching “ACADIA Pharmaceuticals Inc.”
77 pharma patents match "ACADIA Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 77 pharmaceutical patents matching "ACADIA Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11844764
Agitation process for preparing a carbetocin drug product
granted -
US 11827600
Crystalline forms of trofinetide
granted -
US 11464768
Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
granted -
US 11452721
Formulations of pimavanserin
granted -
US 11191757
Combination of pimavanserin and cytochrome P450 modulators
granted -
US 11161826
Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent
granted -
US 11135211
Pimavanserin for treating impulse control disorder
granted -
US 11091473
Compounds for pain treatment, compositions comprising same, and methods of using same
granted -
US 10953000
Combination of pimavanserin and cytochrome P450 modulators
granted -
US 10849891
Formulations of pimavanserin
granted -
US 10646480
Formulations of pimavanserin
granted -
US 10525046
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 10517860
Combination of pimavanserin and cytochrome P450 modulators
granted -
US 10449185
Formulations of pimavanserin
granted -
US 10028944
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 9765053
Methods of treatment using selective 5-HT2A inverse agonists
granted -
US 9757366
Methods for the treatment of parkinson's disease psychosis using pimavanserin
granted -
US 9670209
Muscarinic agonists
granted -
US 9566271
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 9522906
Tetrahydroquinoline analogues as muscarinic agonists
granted -
US 9446037
Methods for the treatment of parkinson's disease psychosis using pimavanserin
granted -
US 9296694
Azacyclic compounds
granted -
US 9211289
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
granted -
US 9061981
Diphenyl substituted cyclohexane derivatives, useful as modulators of the estrogen receptors beta
granted